Search research articles
Contact Us
Filters
Showing results (1-10 of 34) with videos related to
Page
of 4
Sort By:
JCI Insight
|
March 15, 2017
Setting the target for pemphigus vulgaris therapy
Christoph T Ellebrecht, Aimee S Payne
The Journal of Investigative Dermatology
|
March 21, 2014
Plakophilins, desmogleins, and pemphigus: the tail wagging the dog
Christoph T Ellebrecht, Aimee S Payne
The Journal of Investigative Dermatology
|
November 10, 2021
Pemphigus and Pemphigoid: From Disease Mechanisms to Druggable Pathways
Christoph T Ellebrecht, Damian Maseda, Aimee S Payne
Current Opinion in Immunology
|
September 30, 2019
On the mark: genetically engineered immunotherapies for autoimmunity
Christoph T Ellebrecht, Daniel K Lundgren, Aimee S Payne
Cytokine
|
December 4, 2014
The dual nature of interleukin-10 in pemphigus vulgaris
Michael Jeffrey Cho, Christoph T Ellebrecht, Aimee S Payne
JCI Insight
|
May 5, 2017
Stat3 regulates desmoglein 3 transcription in epithelial keratinocytes
Xuming Mao, Michael Jeffrey T Cho, Christoph T Ellebrecht, et al.
Journal of Cutaneous Pathology
|
September 2, 2022
Lichen-planus-pemphigoides-like reaction to PD-1 checkpoint blockade
Margaret Wat, Nicholas K Mollanazar, Christoph T Ellebrecht, et al.
Nature Reviews. Disease Primers
|
February 23, 2018
Authors' reply: Paraneoplastic autoimmune multi-organ syndrome is a distinct entity from traditional pemphigus subtypes
Aimee S Payne, Michael Kasperkiewicz, Christoph T Ellebrecht, et al.
Nature Reviews. Disease Primers
|
May 12, 2018
Correction: Paraneoplastic autoimmune multiorgan syndrome and paraneoplastic pemphigus describe the same spectrum of disease pathology
Aimee S Payne, Michael Kasperkiewicz, Christoph T Ellebrecht, et al.
Nature Reviews. Disease Primers
|
May 12, 2017
Pemphigus
Michael Kasperkiewicz, Christoph T Ellebrecht, Hayato Takahashi, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 34) with videos related to
Sort By:
Page
of 4
JCI Insight
|
March 15, 2017
Setting the target for pemphigus vulgaris therapy
Christoph T Ellebrecht, Aimee S Payne
The Journal of Investigative Dermatology
|
March 21, 2014
Plakophilins, desmogleins, and pemphigus: the tail wagging the dog
Christoph T Ellebrecht, Aimee S Payne
The Journal of Investigative Dermatology
|
November 10, 2021
Pemphigus and Pemphigoid: From Disease Mechanisms to Druggable Pathways
Christoph T Ellebrecht, Damian Maseda, Aimee S Payne
Current Opinion in Immunology
|
September 30, 2019
On the mark: genetically engineered immunotherapies for autoimmunity
Christoph T Ellebrecht, Daniel K Lundgren, Aimee S Payne
Cytokine
|
December 4, 2014
The dual nature of interleukin-10 in pemphigus vulgaris
Michael Jeffrey Cho, Christoph T Ellebrecht, Aimee S Payne
JCI Insight
|
May 5, 2017
Stat3 regulates desmoglein 3 transcription in epithelial keratinocytes
Xuming Mao, Michael Jeffrey T Cho, Christoph T Ellebrecht, et al.
Journal of Cutaneous Pathology
|
September 2, 2022
Lichen-planus-pemphigoides-like reaction to PD-1 checkpoint blockade
Margaret Wat, Nicholas K Mollanazar, Christoph T Ellebrecht, et al.
Nature Reviews. Disease Primers
|
February 23, 2018
Authors' reply: Paraneoplastic autoimmune multi-organ syndrome is a distinct entity from traditional pemphigus subtypes
Aimee S Payne, Michael Kasperkiewicz, Christoph T Ellebrecht, et al.
Nature Reviews. Disease Primers
|
May 12, 2018
Correction: Paraneoplastic autoimmune multiorgan syndrome and paraneoplastic pemphigus describe the same spectrum of disease pathology
Aimee S Payne, Michael Kasperkiewicz, Christoph T Ellebrecht, et al.
Nature Reviews. Disease Primers
|
May 12, 2017
Pemphigus
Michael Kasperkiewicz, Christoph T Ellebrecht, Hayato Takahashi, et al.
Page
of 4